Your browser doesn't support javascript.
loading
Niraparib and Abiraterone Acetate for Metastatic Castration-Resistant Prostate Cancer.
Chi, Kim N; Rathkopf, Dana; Smith, Matthew R; Efstathiou, Eleni; Attard, Gerhardt; Olmos, David; Lee, Ji Youl; Small, Eric J; Pereira de Santana Gomes, Andrea J; Roubaud, Guilhem; Saad, Marniza; Zurawski, Bogdan; Sakalo, Valerii; Mason, Gary E; Francis, Peter; Wang, George; Wu, Daphne; Diorio, Brooke; Lopez-Gitlitz, Angela; Sandhu, Shahneen.
Affiliation
  • Chi KN; BC Cancer - Vancouver Center, University of British Columbia, Vancouver, BC, Canada.
  • Rathkopf D; Memorial Sloan Kettering Cancer Center and Weill Cornell Medicine, New York, NY.
  • Smith MR; Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA.
  • Efstathiou E; Houston Methodist Cancer Center, Houston, TX.
  • Attard G; University College London, London, UK.
  • Olmos D; Department of Medical Oncology, Hospital Universitario 12 de Octubre, Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), Madrid, Spain.
  • Lee JY; Department of Urology Cancer Center, Seoul St Mary's Hospital, The Catholic University of Korea, Seoul, South Korea.
  • Small EJ; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA.
  • Pereira de Santana Gomes AJ; Liga Norte Riograndense Contra o Câncer, Natal, Brazil.
  • Roubaud G; Department of Medical Oncology, Institut Bergonié, Bordeaux, France.
  • Saad M; Department of Clinical Oncology, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.
  • Zurawski B; Department of Outpatient Chemotherapy, Professor Franciszek Lukaszczyk Oncology Center, Bydgoszcz, Poland.
  • Sakalo V; Kyiv City Clinical Oncology Center and Academician O.F. Vozianov Institute of Urology of the National Academy of Medical Sciences of Ukraine, Kyiv, Ukraine.
  • Mason GE; Janssen Research & Development, LLC, Spring House, PA.
  • Francis P; Janssen Research & Development, LLC, Raritan, NJ.
  • Wang G; Janssen Research & Development, LLC, Spring House, PA.
  • Wu D; Janssen Research & Development, LLC, Los Angeles, CA.
  • Diorio B; Janssen Research & Development, LLC, Titusville, NJ.
  • Lopez-Gitlitz A; Janssen Research & Development, LLC, Los Angeles, CA.
  • Sandhu S; Peter MacCallum Cancer Centre and the University of Melbourne, Melbourne, Australia.
J Clin Oncol ; 41(18): 3339-3351, 2023 06 20.
Article in En | MEDLINE | ID: mdl-36952634
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms, Castration-Resistant / Abiraterone Acetate Type of study: Clinical_trials / Prognostic_studies Limits: Humans / Male Language: En Journal: J Clin Oncol Year: 2023 Document type: Article Affiliation country: Canadá Country of publication: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms, Castration-Resistant / Abiraterone Acetate Type of study: Clinical_trials / Prognostic_studies Limits: Humans / Male Language: En Journal: J Clin Oncol Year: 2023 Document type: Article Affiliation country: Canadá Country of publication: Estados Unidos